AMRI launches aseptic API line in Spain
AMRI has launched its new multipurpose aseptic API line at its facility in Valladolid, Spain. The line expands capacity at the site and complements AMRI's other aseptic API manufacturing plants in Bon Encontre and Tonneins, France.
This investment, along with the build-out of analytical services and a new warehouse, provides additional capacity, technology and capabilities for increasing demand for sterile API.
"We continue to see an increase in interest in our sterile capabilities and are ready to support increasing demand," said Michael J. Mulhern, chief executive officer of AMRI. "By adding critical analytical services, we are well-positioned to help customers accelerate the pace of their product development while ensuring their performance and quality."
AMRI's lines are designed to meet requirements from pilot-scale to multi-ton scale manufacturing, and the company's sterilization capability can be integrated with API production or operate as a separate outsourced step for customers who do not have bulk sterile facilities or who may need additional capacity. The company also offers integration with drug product capabilities.
"We would like to thank the region of Castilla y León for their generosity and continued support," said Mr. Mulhern. "There is a talented scientific and engineering workforce in the region and we are happy to reaffirm our commitment to the region and the expansion of our capabilities and expertise to customers in Europe."